+467.0%
MRNA vs FTAI
+11.7%
+455.4%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | FTAI | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +3.3% | +2.1% | +4.1% |
| 7D | -1.1% | -5.2% | +4.1% | +0.9% |
| 30D | +126.1% | -17.9% | +144.0% | +143.6% |
| 3M | +190.0% | -22.7% | +212.8% | +215.3% |
| 6M | +157.2% | -28.0% | +185.2% | +183.0% |
| YTD | +388.2% | -5.0% | +393.2% | +378.0% |
| 1Y | +467.0% | +10.4% | +456.6% | +424.2% |
| All | +467.0% | +11.7% | +455.4% | +424.2% |
Cumulative growth
Daily Returns
Daily percentage return beside FTAI.
Daily Out/Under-Performance
Portfolio return minus FTAI return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × FTAI return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded FTAI wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling